Business briefs: Lundbeck, FDA, Tower Watson and National Business Group Study, Merck
March 7, 2013
5:01 pm
Lundbeck and Otsuka deepen their Abilify co-promotion partnership; study finds FDA clinical trial rule isn’t sticking; another study confirms that employees are paying more for health insurance as employers pay less; Merck appoints new R&D chief
Business briefs: Amgen and Omnicom Group
February 12, 2013
10:31 pm
Amgen said they will continue to spread out their efforts on two different commercial models: biologics and biosimilars.
Business briefs: Takeda, Google, Lundbeck, Elan, Teva
February 7, 2013
7:30 pm
Takeda’s 1,800 field reps are getting a new tool, Google changes its AdWords program.
Facing lower-than-expected demand, Purdue and Transcept are broadening the commercial strategy for Intermezzo to include DTC and a larger selling force.
Payers render traditional marketing outmoded, says study
GlaxoSmithKline’s Dierdre Connelly peeled back the curtain on the company’s sales force incentives revamp in a speech to the Pharmaceutical Regulatory and Compliance Congress, and pleaded for recognition that the industry had cleaned up the sketchy practices of the Blockbuster Era.
Amgen’s Prolia, Enbrel get sales overhauls, DTC
October 24, 2012
8:22 pm
Sales of Amgen’s Prolia are set to rise after a “soft” quarter, thanks to a sales force overhaul and an impending return to TV advertising, the company said in a third quarter results call.